AA, Y., IG, J., JR, P., HE, B., HA, H., DS, O., . . . KA, C. (2025). PACT suppresses PKR activation through dsRNA binding and dimerization, and is a therapeutic target for triple-negative breast cancer. RNA (New York, N.Y.), 31(11), 1599. https://doi.org/10.1261/rna.080637.125
Chicago Style (17th ed.) CitationAA, Young, et al. "PACT Suppresses PKR Activation Through DsRNA Binding and Dimerization, and Is a Therapeutic Target for Triple-negative Breast Cancer." RNA (New York, N.Y.) 31, no. 11 (2025): 1599. https://doi.org/10.1261/rna.080637.125.
MLA (9th ed.) CitationAA, Young, et al. "PACT Suppresses PKR Activation Through DsRNA Binding and Dimerization, and Is a Therapeutic Target for Triple-negative Breast Cancer." RNA (New York, N.Y.), vol. 31, no. 11, 2025, p. 1599, https://doi.org/10.1261/rna.080637.125.